Search Results - "Hainaut, Pierre"
-
1
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Published in Nature reviews. Gastroenterology & hepatology (01-10-2019)“…Hepatocellular carcinoma (HCC) is the fourth most common cause of cancer-related death worldwide. Risk factors for HCC include chronic hepatitis B and…”
Get full text
Journal Article -
2
Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li–Fraumeni syndrome
Published in Current opinion in oncology (01-01-2018)“…PURPOSE OF REVIEWGermline pathogenic TP53 mutation may predispose to multiple cancers but penetrance and cancer patterns remain incompletely documented. We…”
Get full text
Journal Article -
3
Massively regulated genes: the example of TP53
Published in The Journal of pathology (01-01-2010)“…Intensive study of the TP53 gene over the last three decades has revealed a highly complex network of factors that regulate its performance. The gene has…”
Get full text
Journal Article -
4
Genetics of lung-cancer susceptibility
Published in The lancet oncology (01-04-2011)“…Summary Lung cancer is the most common form of cancer death worldwide. Although reduction of tobacco consumption remains the most appropriate strategy to…”
Get full text
Journal Article -
5
Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles
Published in BMC cancer (10-02-2020)“…TP53 mutations occur in only about 3% of primary and 10-20% of relapse B-cell precursor acute lymphoblastic leukaemia (BCP-ALL). However, alternative…”
Get full text
Journal Article -
6
The TP53 Database: transition from the International Agency for Research on Cancer to the US National Cancer Institute
Published in Cell death and differentiation (01-05-2022)Get full text
Journal Article -
7
Identification of osteopontin as a novel marker for early hepatocellular carcinoma
Published in Hepatology (Baltimore, Md.) (01-02-2012)“…The aim of this study was to identify a biomarker that could improve alpha‐fetoprotein (AFP) performance in hepatocellular carcinoma (HCC) surveillance among…”
Get full text
Journal Article -
8
Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
Published in Molecular oncology (01-06-2007)“…The development of cancer is driven by the accumulation of scores of alterations affecting the structure and function of the genome. Equally important in this…”
Get full text
Journal Article -
9
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers
Published in Science translational medicine (22-05-2013)“…Activation of normally silent tissue-specific genes and the resulting cell "identity crisis" are the unexplored consequences of malignant epigenetic…”
Get more information
Journal Article -
10
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
Published in Mutation research (01-05-2007)“…The presence of small amounts of tumor DNA in cell free DNA (CFDNA) circulating in the plasma or serum of cancer patients was first demonstrated 30 years ago…”
Get full text
Journal Article -
11
The aflatoxin-induced TP53 mutation at codon 249 ( R249S ): Biomarker of exposure, early detection and target for therapy
Published in Cancer letters (01-12-2009)“…Abstract Hepatocellular Carcinoma (HCC) in high-incidence areas (sub-Saharan Africa, South-Eastern Asia) often contains a somatic mutation at codon 249 in TP53…”
Get full text
Journal Article -
12
Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence
Published in Antioxidants & redox signaling (15-09-2011)“…The p53 tumor suppressor protein has achieved stardom in molecular oncology owing to frequent inactivation in a large range of cancers. Known as a factor…”
Get more information
Journal Article -
13
Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
Published in Journal of clinical oncology (10-06-2013)“…We undertook this analysis of KRAS mutation in four trials of adjuvant chemotherapy (ACT) versus observation (OBS) to clarify the prognostic/predictive roles…”
Get full text
Journal Article -
14
Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients
Published in Proceedings of the National Academy of Sciences - PNAS (27-01-2015)“…Significance In cancer, the metabolism of copper and sulfur are dysregulated, leading to deleterious side effects. These issues are commonly addressed by…”
Get full text
Journal Article -
15
PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
Published in Cancer cell (05-05-2009)“…Restoration of wild-type p53 expression triggers cell death and eliminates tumors in vivo. The identification of mutant p53-reactivating small molecules such…”
Get full text
Journal Article -
16
Role of Obesity in the Risk of Breast Cancer: Lessons from Anthropometry
Published in Journal of Oncology (01-01-2013)“…An estimated 1.38 million new cases of breast cancer (BC) are diagnosed each year in women worldwide. Of these, the majority are categorized as invasive ductal…”
Get full text
Journal Article -
17
Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells
Published in PloS one (25-10-2011)“…Plasmacytoid dendritic cells (pDCs) play a key role in detecting pathogens by producing large amounts of type I interferon (IFN) by sensing the presence of…”
Get full text
Journal Article -
18
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma
Published in PloS one (23-03-2017)“…Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide, but is still lacking sensitive and specific biomarkers for early…”
Get full text
Journal Article -
19
Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer
Published in Genes & development (01-04-2016)“…Pancreatic ductal adenocarcinoma (PDAC) is a lethal form of cancer with few therapeutic options. We found that levels of the lysine methyltransferase SMYD2…”
Get full text
Journal Article -
20
Roles of thioredoxin reductase 1 and APE Ref-1 in the control of basal p53 stability and activity
Published in Oncogene (02-06-2005)“…The p53 protein is redox-sensitive in vitro but in vivo effectors of this sensitivity are not known. In yeasts deficient for thioredoxin (Trx) reductase (TRR),…”
Get full text
Journal Article